Please select the option that best describes you:
Topics:
Thoracic Malignancies • Medical Oncology
What is the appropriate concurrent chemoradiation regimen to treat unresectable stage IIB lung adenocarcinoma?
Is there any role for immunotherapy?
Answer from: Radiation Oncologist at Community Practice
Historically, many locally advanced NSCLC trials have included patients with unresectable stage II disease. While those patients comprised only a few % of the study population, I think it is largely reasonable to extrapolate findings from stage III NSCLC patients to patients with unresectable stage ...
Sign in or Register to read more
Answer from: Medical Oncologist at Community Practice
In this patient population where we do not have data to guide treatment decisions, S1933 is a potential option. This study targets stage II patients who are not surgical candidates and stage III patients with ECOG PS 2. Patients are treated with hypofractionated radiotherapy followed by atezolizumab...